当前位置:首页 - 行情中心 - 振东制药(300158) - 财务分析 - 现金流量表

振东制药

(300158)

  

流通市值:67.92亿  总市值:67.96亿
流通股本:10.05亿   总股本:10.05亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,822,908,395.791,250,597,839.31597,926,743.453,319,611,511.92
  收到的税费返还21,352,286.7312,665,221.362,202,225.4418,807,255.69
  收到其他与经营活动有关的现金27,844,827.7720,861,970.382,755,281.946,342,746.42
  经营活动现金流入小计1,872,105,510.291,284,125,031.05602,884,250.793,384,761,514.03
  购买商品、接受劳务支付的现金859,989,462.17555,677,523.68266,383,537.071,578,892,269.37
  支付给职工以及为职工支付的现金359,753,615.16263,239,406.19105,579,509.57490,614,808.7
  支付的各项税费137,371,150.8977,070,594.3730,713,845.79202,215,937.81
  支付其他与经营活动有关的现金1,117,728,132.64791,077,667.14530,217,295.531,262,860,751.24
  经营活动现金流出小计2,474,842,360.861,687,065,191.38932,894,187.963,534,583,767.12
  经营活动产生的现金流量净额-602,736,850.57-402,940,160.33-330,009,937.17-149,822,253.09
二、投资活动产生的现金流量:
  收回投资收到的现金2,626,599,0002,112,499,0001,248,499,0006,346,477,714.16
  取得投资收益收到的现金10,752,321.848,895,470.024,157,586.5646,968,868.97
  处置固定资产、无形资产和其他长期资产收回的现金净额1,024,266.1324,266.13-7,770,836.6
  处置子公司及其他营业单位收到的现金净额---988,384.1
  投资活动现金流入小计2,638,375,587.972,121,418,736.151,252,656,586.566,402,205,803.83
  购建固定资产、无形资产和其他长期资产支付的现金119,587,834.6968,305,950.7726,579,151.77298,476,228.4
  投资支付的现金2,127,354,9001,708,003,000967,003,0006,064,217,554.34
  投资活动现金流出小计2,246,942,734.691,776,308,950.77993,582,151.776,362,693,782.74
  投资活动产生的现金流量净额391,432,853.28345,109,785.38259,074,434.7939,512,021.09
三、筹资活动产生的现金流量:
  取得借款收到的现金---38,109,647.77
  收到其他与筹资活动有关的现金33,210,307.326,254,686.721,766,957.9991,850,241.31
  筹资活动现金流入小计33,210,307.326,254,686.721,766,957.99129,959,889.08
  偿还债务支付的现金33,637,40030,637,400150,00053,350,000
  分配股利、利润或偿付利息支付的现金148,348.21148,348.2182,462.2584,652.53
  支付其他与筹资活动有关的现金62,831,992.4566,636,021.1161,638,214.31170,518,396.79
  筹资活动现金流出小计96,617,740.6697,421,769.3261,870,676.51224,453,049.32
  筹资活动产生的现金流量净额-63,407,433.36-71,167,082.62-40,103,718.52-94,493,160.24
五、现金及现金等价物净增加额-274,711,430.65-128,997,457.57-111,039,220.9-204,803,392.24
  加:期初现金及现金等价物余额558,015,272.49558,015,272.49558,015,272.49762,818,664.73
  期末现金及现金等价物余额283,303,841.84429,017,814.92446,976,051.59558,015,272.49
补充资料:
  净利润-6,503,597.16--1,332,939,095.45
  资产减值准备-10,736,851.69-290,875,553.09
  固定资产和投资性房地产折旧-44,037,416.92-92,889,781.6
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-44,037,416.92-92,889,781.6
  无形资产摊销-11,977,974.05-20,679,341.22
  长期待摊费用摊销-3,711,433.62-5,475,613.69
  处置固定资产、无形资产和其他长期资产的损失--4,604.73--11,256,735.65
  固定资产报废损失--24,016.13-712,593.1
  公允价值变动损失--1,328,710.16-139,440,121.7
  财务费用-1,230,174.45-3,900,426.39
  投资损失--6,519,141.08--41,972,827.58
  递延所得税-1,084,921.23--3,275,343.82
  其中:递延所得税资产减少-966,779.54--3,957,060.89
    递延所得税负债增加-118,141.69-681,717.07
  存货的减少-185,984,818.62-176,504,093.1
  经营性应收项目的减少--170,981,671.02-114,995,475.58
  经营性应付项目的增加--488,884,420.51-270,363,450.63
  其他--464,784.44-122,768,092
  现金的期末余额-429,017,814.92-558,015,272.49
  减:现金的期初余额-558,015,272.49-762,818,664.73
  现金及现金等价物的净增加额--128,997,457.57--204,803,392.24
公告日期2025-10-232025-08-252025-04-212025-04-21
审计意见(境内)标准无保留意见
TOP↑